Translate
Clinical Trials View (Global Monitor)
Integrated healthcare clinical trials portal. Track patient recruitment ratios, investigate clinical site locations globally, and monitor regulatory safety holds utilizing dynamic timeline indicators and real-time visualization frameworks.
LIVE|00:19
Total Registered Studies
15 Ingested
Overall Enrollment Rate
68%
OptimalInvestigational Sites
16 Global Centers
Active Protocol Safety Holds
0 Blocked
Live Core Active Trial Registry15 In Stream
NCT04078230
RecruitingRegional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Sponsor: Second Affiliated Hospital, Zhejiang University, School of MedicineExtend LymphAdenectomy
Recruitment velocity & actual vs target:125 / 168 patients (74%)
NCT07036328
RecruitingTranscranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease
Sponsor: Willem de Haanrepetitive transcranial magnetic stimulation, sham repetitive transcranial magnetic stimulation
Recruitment velocity & actual vs target:35 / 55 patients (64%)
NCT06828328• Phase I
RecruitingA Study of GC203 TIL in PDCA (RJ)
Sponsor: Shanghai Juncell TherapeuticsGC203 TIL
Recruitment velocity & actual vs target:5 / 10 patients (50%)
NCT06413667
RecruitingAssessment of the Alignment of the Atlas and Surrounding Tissues in Chronic Whiplash Associated Disorder
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/A
Recruitment velocity & actual vs target:63 / 90 patients (70%)
NCT05856565
RecruitingGeneration of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Predictive Factor of Response to Anti-PD-1
Sponsor: Nantes University HospitalPhoto
Recruitment velocity & actual vs target:458 / 700 patients (65%)
NCT06875765
RecruitingLong-term Longitudinal Imaging of Presynaptic Terminals in PD
Sponsor: Universitaire Ziekenhuizen KU Leuven11C-UCB-J PET-CT, 18F-PE2I PET-CT, MRI brain
Recruitment velocity & actual vs target:28 / 35 patients (80%)
NCT06280807
RecruitingObservation of Environment and Reproductive-Endocrine Effects
Sponsor: National Institute of Environmental Health Sciences (NIEHS)N/A
Recruitment velocity & actual vs target:188 / 300 patients (63%)
NCT06738407• Phase IV
RecruitingDoxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Sponsor: WestatDoxycycline hyclate delayed released 200 mg, Doxycycline hyclate delayed released 200 mg weekly, Per standard of care with quarterly STI testing/treatment and sexual health counseling
Recruitment velocity & actual vs target:477 / 760 patients (63%)
NCT04092192
RecruitingForceps vs. Snare IVC Filter Removal
Sponsor: University of ChicagoIVC filter removal
Recruitment velocity & actual vs target:61 / 100 patients (61%)
NCT00900471
RecruitingCollection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Sponsor: Wake Forest University Health Sciencesbiologic sample preservation procedure, medical chart review
Recruitment velocity & actual vs target:13715 / 20000 patients (69%)
NCT06933134
RecruitingProspective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis
Sponsor: University Hospital, ToursN/A
Recruitment velocity & actual vs target:20 / 30 patients (67%)
NCT07064434
RecruitingSacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension
Sponsor: General Hospital of Ningxia Medical UniversitySacral canal block combined with general anesthesia, Simple general anesthesia
Recruitment velocity & actual vs target:52 / 80 patients (65%)
NCT07025434
RecruitingEffects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
Sponsor: Dominican University New YorkHip Bump Manipulation, Sham (No Treatment)
Recruitment velocity & actual vs target:49 / 60 patients (82%)
NCT06998264
RecruitingIn-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children
Sponsor: University Hospital, GenevaN/A
Recruitment velocity & actual vs target:20 / 40 patients (50%)
NCT04288999• Phase III
RecruitingSurgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Sponsor: National Cancer Center Hospital EastChemotherapy, Preoperative radiotherapy, Procedure
Recruitment velocity & actual vs target:67 / 110 patients (61%)
Enrollment Statistics Analyzer
- Actual Enrollment
- Target Enrollment
*The index compares target protocol enrollment against current actively documented site records to compute recruitment velocity models. NCT06240182 maintains maximum acceleration parameters.
Premium Feature Locked
This section is only visible for subscriber only. Please log in or upgrade your account to access live site locations and regulatory protocol evaluations.
Site Locations & Investigators
Audited clinical operational registries. Filter by continent to reveal regional site densities, principal investigators, and active treatment numbers.
Medical Center 1 (United States)
Visual Geographic GIS Overlay EnabledScope: US
Medical Center 1
United States • Lead: Dr. Investigator
Protocal Target: Extend LymphAdenectomy (NCT04078230)
12 ActiveEnrolling
Regulatory Protocol EvaluatorAI Enabled
NCT04078230 • Second Affiliated Hospital, Zhejiang University, School of Medicine
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Investigative CompoundExtend LymphAdenectomy
Critical Risk StatusNone
Estimated Final Readout2027-12-31
Participating Centers2 Active Sites
CURA Intellect Audit advice: Use clinical trials registries insights inside target folders. Combine clinical whitespace assessments to mitigate generic/bio-equivalent entrant timelines.
